PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 2222796

Amperometric immunoassay.

D Monroe
View original source ↗Export metadata ↓

Abstract

An exciting new analytical technique based on amperometric devices used to measure immunoassays is reviewed in this article. The utility, ease, speed, simplicity, and many other advantages of performing amperometric immunoassays (AIAs) are discussed throughout the review. Limitations are also described, with electrochemical comparisons being made between AIAs and other conventional analytical methods, including potentiometric immunoassays. The review essentially consists of a general AIA overview, followed by sections devoted to amperometric electrode types, assay design, basic principles, automation, application, and future use. Operational features of oxygen gas selective electrodes and oxidoreductase probes are discussed for a better understanding of AIA principles. Characteristics, limits, advantages, and disadvantages of these different devices are presented. A variety of homogeneous and heterogeneous AIAs are described, together with many applications of the different assay formats available. AIAs are classified according to the electrode type employed, enzyme labels required, or electrochemical components involved. Important related AIAs discussed include pulse agglutination reactions and bioaffinity or displacement assays.

Explore related subjects

Affinity LabelsAutomationBinding, CompetitiveElectrochemistryElectrodesEvaluation Studies as TopicImmunoassayMolecular ProbesOxidation-ReductionOxygenComparative StudyJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D Monroe. 1990. Amperometric immunoassay.. https://doi.org/10.3109/10408369009105895

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome.

ProteomeBinders is a new European consortium aiming to establish a comprehensive resource of well-characterized affinity reagents, including but not limited to antibodies, for analysis of the human proteome. Given the huge diversity of the proteome, the scale of the project is potentially immense but nevertheless feasible in the context of a pan-European or even worldwide coordination.

Affinity Labels↗
PubMed2006

Synthesis of novel caspase inhibitors for characterization of the active caspase proteome in vitro and in vivo.

Caspases are cysteine proteases that are essential for cytokine maturation and apoptosis. To facilitate the dissection of caspase function in vitro and in vivo, we have synthesized irreversible caspase inhibitors with biotin attached via linker arms of various lengths (12a-d) and a 2,4-dinitrophenyl labeled inhibitor (13). Affinity labeling of apoptotic extracts followed by blotting reveals that these affinity probes detect active caspases. Using the strong affinity of avidin for biotin, we have isolated affinity-labeled caspase 6 from apoptotic cytosolic extracts of cells overexpressing procaspase 6 by treatment with 12c, which contains biotin attached to the N(epsilon)-lysine of the inhibitor by a 22.5 A linker arm, followed by affinity purification on monomeric avidin-sepharose beads. Compound 13 has proven sufficiently cell permeable to rescue cells from apoptotic execution. These novel caspase inhibitors should provide powerful probes for the study of the active caspase proteome during apoptosis both in vitro and in vivo.

Affinity Labels↗
PubMed2006

Removal of contaminating DNA from polymerase chain reaction using ethidium monoazide.

The presence of exogenous DNA in PCR reagents and DNA polymerase is a common occurrence. In particular, the amplification of 16S rRNA genes with universal primers for non-culture-based study is often hampered by the formation of false positives. Here, we describe the use of ethidium monoazide (EMA) to eliminate contaminating DNA in a polymerase chain reaction. The advantage of the proposed methodology is the retention of the highly sensitive nature of PCR with the ability to amplify template DNA at concentrations lower than those of contaminating DNA. The treatment of PCR master mix with EMA concentrations that exceeded those required to remove contaminating DNA can interfere with the amplification of low-template concentrations. The methodology presented is straightforward and can be accomplished within 10 min.

Affinity Labels↗